Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Results of a phase I clinical trial-Reference-Cited by-同舟云学术

Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: Results of a phase I clinical trial

Published:2006-06-01 Issue:8 Volume:66 Page:811-821
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Fuessel Susanne,Meye Axel,Schmitz Marc,Zastrow Stefan,Linné Clemens,Richter Katja,Löbel Barbel,Hakenberg Oliver W.,Hoelig Kristina,Rieber E. Peter,Wirth Manfred P.

Publisher

Wiley

Subject

Urology,Oncology

Reference57 articles.

1. Cancer Statistics, 2005

2. CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS

3. Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer

4. Natural History of Progression After PSA Elevation Following Radical Prostatectomy

5. Clinical trials in metastatic prostate cancer – Has there been real progress in the past decade?

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges of targeting tumor microenvironment in prostate cancer;New Updates in Tumor Microenvironment [Working Title];2024-08-14

2. A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models;Science Translational Medicine;2024-08-07

3. Immune mediated support of metastasis: Implication for bone invasion;Cancer Communications;2024-07-14

4. Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer;Life;2023-07-01

5. Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer;Frontiers in Immunology;2021-03-29